Background Differentiated thyroid cancer (DTC) work-up is based on (near) total-
thyroidectomy plus thyroid remnant ablation (TRA) with 131-radioiodine in many patients …

Objective Surgery and radioactive iodine (RAI) ablation constitute the mainstay of the
treatment of differentiated thyroid carcinoma (DTC). In this study, we aimed to evaluate the …

Differentiated thyroid cancer (DTC) generally has a favorable prognosis. However, a small
percentage of patients suffer from initial distant metastasis (DM). To date, there is no …

Purpose An accurate postoperative assessment is pivotal to inform postoperative 131I
treatment in patients with differentiated thyroid cancer (DTC). We developed a predictive …

Serum thyroglobulin is used as part of the early postoperative assessment of differentiated
thyroid cancer (DTC) since there is a clear relationship between an increased risk of …

Background: Guidelines for the follow-up of differentiated thyroid cancer (DTC) recommend
the measurement of TSH-stimulated thyroglobulin (s-Tg) instead of basal Tg on T< sub> …

Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …

Background: Postsurgical thyrotropin (TSH)-stimulated serum thyroglobulin (Tg) level can be
used to predict the likelihood of finding radioactive iodine (RAI) avid metastatic foci on …

Objective: To investigate the usefulness of whole body scan (WBS) and serum thyroglobulin
(Tg) measurement after thyroxine withdrawal during sequential follow-ups in patients with …

Radioiodine (RAI) is selectively recommended for intermediate-risk differentiated thyroid
carcinomas (DTC). The information gleaned from pretherapy stimulated thyroglobulin levels …